News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
no_data1Amazon is Considering a $9 Billion Deal to Acquire Satellite Communications Company Globalstar. Here's Why Amazon, Apple, and Tesla Investors Should Pay Attention.2Exxon’s Guyana-Permian Engine Fuels 21% Earnings Growth—Is the 24 P/E Already Discounting a Squeeze?3Bitcoin’s Movement Compared to Oil’s Rally: Evaluating a Risk-Off Scenario
Flash
11:15
Goldman Sachs private credit fund defies the trend to address industry redemption waveGolden Ten Data, April 6 — Goldman Sachs’ private credit fund stated that the percentage of shares investors sought to redeem in the first quarter was slightly below 5%. All redemption requests have been fulfilled and are below its quarterly redemption cap. In a regulatory filing submitted on Monday, the company noted: “We believe these results highlight Goldman Sachs Credit’s strong position relative to the broader non-traded BDC (Business Development Company) sector. We are the only non-traded BDC among our peers with redemption requests below the 5% standard quarterly cap.”
11:05
Coeur Mining today announced the early participation results for the previously announced exchange offer for new gold senior notes and consent solicitation.This announcement marks significant progress in the company's debt optimization process, providing a clear signal of capital structure improvement to the market.
11:05
Sagimet Biosciences Inc. (hereinafter referred to as "Sagimet") announced that its latest research progress will be presented at the "Fueling MASH: Metabolic Drivers and Inflammatory Interactions" Keystone Symposium through poster and oral presentations.This conference will bring together top experts in the field to jointly discuss the latest scientific discoveries related to metabolic dysfunction-associated steatohepatitis (MASH). Meanwhile, the company also disclosed that, in accordance with Nasdaq Listing Rule 5635(c)(4), it has granted an inducement equity award to new employees. Such awards are a common practice among biotechnology companies, aimed at attracting high-quality talent and advancing the company's research and development pipeline.
News